ID22273A - BENZENASULFONAMIDA TIAZOL AS A β AGONIST FOR TREATMENT OF DIABETES AND OBESITY - Google Patents
BENZENASULFONAMIDA TIAZOL AS A β AGONIST FOR TREATMENT OF DIABETES AND OBESITYInfo
- Publication number
- ID22273A ID22273A IDW990755A ID990755A ID22273A ID 22273 A ID22273 A ID 22273A ID W990755 A IDW990755 A ID W990755A ID 990755 A ID990755 A ID 990755A ID 22273 A ID22273 A ID 22273A
- Authority
- ID
- Indonesia
- Prior art keywords
- benzenasulfonamida
- tiazol
- obesity
- agonist
- diabetes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3676097P | 1997-01-28 | 1997-01-28 | |
GBGB9705041.3A GB9705041D0 (en) | 1997-03-12 | 1997-03-12 | Thiazole benzenesulfonamides as selective B3 agonists for the treatment of diabetes and obesity |
Publications (1)
Publication Number | Publication Date |
---|---|
ID22273A true ID22273A (en) | 1999-09-23 |
Family
ID=26311166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW990755A ID22273A (en) | 1997-01-28 | 1998-01-23 | BENZENASULFONAMIDA TIAZOL AS A β AGONIST FOR TREATMENT OF DIABETES AND OBESITY |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0968209A1 (en) |
JP (1) | JP2001509166A (en) |
KR (1) | KR20000070568A (en) |
CN (1) | CN1251099A (en) |
AR (1) | AR011092A1 (en) |
AU (1) | AU728812B2 (en) |
BG (1) | BG103686A (en) |
BR (1) | BR9807096A (en) |
CA (1) | CA2278739A1 (en) |
EA (1) | EA199900692A1 (en) |
EE (1) | EE9900328A (en) |
HR (1) | HRP980044A2 (en) |
HU (1) | HUP0002053A3 (en) |
ID (1) | ID22273A (en) |
IL (1) | IL131130A0 (en) |
IS (1) | IS5131A (en) |
NO (1) | NO993646L (en) |
PE (1) | PE52299A1 (en) |
PL (1) | PL334833A1 (en) |
SK (1) | SK100099A3 (en) |
TR (1) | TR199902442T2 (en) |
WO (1) | WO1998032753A1 (en) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19824175A1 (en) * | 1998-05-29 | 1999-12-02 | Novartis Ag | Amino azole compounds |
DE60124861T2 (en) | 2000-01-21 | 2007-05-10 | Novartis Ag | COMPOSITIONS CONTAINING DIPEPTIDYLPEPTIDASE-IV INHIBITORS AND ANTIDIABETICA |
WO2001054728A1 (en) * | 2000-01-28 | 2001-08-02 | Asahi Kasei Kabushiki Kaisha | NOVEL REMEDIES WITH THE USE OF β3 AGONIST |
DK1138685T3 (en) | 2000-03-31 | 2004-08-09 | Pfizer Prod Inc | Process for preparing substituted pyridines |
CN1441800A (en) | 2000-07-13 | 2003-09-10 | 伊莱利利公司 | Beta 3 adrenergic agonists |
US6410734B1 (en) | 2000-07-17 | 2002-06-25 | Wyeth | 2-substituted thiazolidinones as beta-3 adrenergic receptor agonists |
US6525202B2 (en) | 2000-07-17 | 2003-02-25 | Wyeth | Cyclic amine phenyl beta-3 adrenergic receptor agonists |
US6537994B2 (en) | 2000-07-17 | 2003-03-25 | Wyeth | Heterocyclic β3 adrenergic receptor agonists |
US6498170B2 (en) | 2000-07-17 | 2002-12-24 | Wyeth | Cyclamine sulfonamides as β-3 adrenergic receptor agonists |
US6465501B2 (en) | 2000-07-17 | 2002-10-15 | Wyeth | Azolidines as β3 adrenergic receptor agonists |
US6369232B1 (en) * | 2000-08-15 | 2002-04-09 | Hoffmann-La Roche Inc. | Tetrazolyl-phenyl acetamide glucokinase activators |
US6825220B2 (en) | 2000-11-10 | 2004-11-30 | Eli Lilly And Company | 3-Substituted oxindole β 3 agonists |
EP1348706B1 (en) | 2000-12-08 | 2009-08-19 | Takeda Pharmaceutical Company Limited | Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
AR035605A1 (en) | 2000-12-11 | 2004-06-16 | Bayer Corp | DERIVATIVES OF AMINOMETIL CHROMANO DI-SUBSTITUTES, A METHOD FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS AND THE USE OF SUCH DERIVATIVES FOR THE MANUFACTURE OF USEFUL MEDICINES AS BETA-3-ADRENE-RECEPTORS AGONISTS |
AR035858A1 (en) | 2001-04-23 | 2004-07-21 | Bayer Corp | CHROME DERIVATIVES 2,6-SUBSTITUTES, PHARMACEUTICAL COMPOSITIONS, USE OF SUCH DERIVATIVES FOR THE MANUFACTURE OF USEFUL MEDICINES AS BETA-3 ADRENORRECEPTING AGONISTS |
DE60208792T2 (en) * | 2001-06-22 | 2006-08-31 | Merck & Co., Inc. | TYROSINE KINASE INHIBITORS |
ES2272749T3 (en) | 2001-08-14 | 2007-05-01 | Eli Lilly And Company | DERIVATIVES OF INDOL AS BETA-3 ADRENERGIC AGONISTS FOR THE TREATMENT OF TYPE 2 DIABETES. |
ES2262817T3 (en) | 2001-08-14 | 2006-12-01 | Eli Lilly And Company | BETA-3 OXINDOL 3-SUBSTITUTED AGONISTS. |
US20050014805A1 (en) * | 2001-10-12 | 2005-01-20 | Chenzhi Zhang | Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity |
WO2003044016A1 (en) | 2001-11-20 | 2003-05-30 | Eli Lilly And Company | 3-SUBSTITUTED OXINDOLE β3 AGONISTS |
EP1448561B1 (en) | 2001-11-20 | 2008-02-20 | Eli Lilly And Company | Beta 3 adrenergic agonists |
JP2005520805A (en) | 2002-01-11 | 2005-07-14 | イーライ・リリー・アンド・カンパニー | 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists |
US6872724B2 (en) | 2002-07-24 | 2005-03-29 | Merck & Co., Inc. | Polymorphs with tyrosine kinase activity |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
US20080125403A1 (en) | 2004-04-02 | 2008-05-29 | Merck & Co., Inc. | Method of Treating Men with Metabolic and Anthropometric Disorders |
WO2006132196A1 (en) * | 2005-06-08 | 2006-12-14 | Asahi Kasei Pharma Corporation | NOVEL PHARMACEUTICAL COMPRISING β3 AGONIST |
WO2007033266A2 (en) | 2005-09-14 | 2007-03-22 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors for treating diabetis |
AU2006297443B2 (en) | 2005-09-29 | 2010-08-12 | Merck Sharp & Dohme Corp. | Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
AU2006302562A1 (en) * | 2005-10-04 | 2007-04-19 | Merck Sharp & Dohme Corp. | Combination therapy for the treatment of urinary frequency, urinary urgency and urinary incontinence |
CA2664113C (en) | 2006-09-22 | 2013-05-28 | Merck & Co., Inc. | Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer |
CA2682727C (en) | 2007-04-02 | 2016-03-22 | Banyu Pharmaceutical Co., Ltd. | Indoledione derivative |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
EP2170930B3 (en) | 2007-06-04 | 2013-10-02 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
JP2011522828A (en) | 2008-06-04 | 2011-08-04 | シナジー ファーマシューティカルズ インコーポレイテッド | Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer, and other disorders |
AU2009270833B2 (en) | 2008-07-16 | 2015-02-19 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
CN102264228A (en) | 2008-10-22 | 2011-11-30 | 默沙东公司 | Novel cyclic benzimidazole derivatives useful for anti-diabetic agents |
AU2009309037A1 (en) | 2008-10-31 | 2010-05-06 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
WO2011041293A1 (en) | 2009-09-30 | 2011-04-07 | Takeda Pharmaceutical Company Limited | Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors |
CN102834393B (en) | 2010-02-03 | 2015-07-22 | 武田药品工业株式会社 | Apoptosis signal-regulating kinase 1 inhibitors |
AU2011218830B2 (en) | 2010-02-25 | 2014-07-24 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
PE20140859A1 (en) | 2011-02-25 | 2014-07-25 | Merck Sharp & Dohme | NOVELTY DERIVATIVES OF CYCLIC AZABENZIMIDAZOLE USEFUL AS ANTIDIABETIC AGENTS |
JP2015525782A (en) | 2012-08-02 | 2015-09-07 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
ES2394349B1 (en) | 2012-08-29 | 2013-11-04 | Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii | Use of selective beta-3 adrenergic receptor agonists for the treatment of pulmonary hypertension |
US9784726B2 (en) | 2013-01-08 | 2017-10-10 | Atrogi Ab | Screening method, a kit, a method of treatment and a compound for use in a method of treatment |
EP2958562A4 (en) | 2013-02-22 | 2016-08-10 | Merck Sharp & Dohme | Antidiabetic bicyclic compounds |
US9650375B2 (en) | 2013-03-14 | 2017-05-16 | Merck Sharp & Dohme Corp. | Indole derivatives useful as anti-diabetic agents |
WO2014151206A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
EP3004138B1 (en) | 2013-06-05 | 2024-03-13 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
EP3551176A4 (en) | 2016-12-06 | 2020-06-24 | Merck Sharp & Dohme Corp. | Antidiabetic heterocyclic compounds |
EP3558298A4 (en) | 2016-12-20 | 2020-08-05 | Merck Sharp & Dohme Corp. | Antidiabetic spirochroman compounds |
GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714740D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB202205895D0 (en) | 2022-04-22 | 2022-06-08 | Atrogi Ab | New medical uses |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0091749A3 (en) * | 1982-04-08 | 1984-12-05 | Beecham Group Plc | Ethanolamine derivatives, process for their preparation and pharmaceutical compositions containing them |
US5451677A (en) * | 1993-02-09 | 1995-09-19 | Merck & Co., Inc. | Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity |
IL113410A (en) * | 1994-04-26 | 1999-11-30 | Merck & Co Inc | Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them |
-
1998
- 1998-01-23 BR BR9807096-7A patent/BR9807096A/en not_active IP Right Cessation
- 1998-01-23 SK SK1000-99A patent/SK100099A3/en unknown
- 1998-01-23 CN CN98803585A patent/CN1251099A/en active Pending
- 1998-01-23 IL IL13113098A patent/IL131130A0/en unknown
- 1998-01-23 PL PL98334833A patent/PL334833A1/en unknown
- 1998-01-23 EE EEP199900328A patent/EE9900328A/en unknown
- 1998-01-23 TR TR1999/02442T patent/TR199902442T2/en unknown
- 1998-01-23 JP JP53214898A patent/JP2001509166A/en active Pending
- 1998-01-23 EP EP98903677A patent/EP0968209A1/en not_active Withdrawn
- 1998-01-23 CA CA002278739A patent/CA2278739A1/en not_active Abandoned
- 1998-01-23 EA EA199900692A patent/EA199900692A1/en unknown
- 1998-01-23 KR KR1019997006814A patent/KR20000070568A/en not_active Application Discontinuation
- 1998-01-23 HU HU0002053A patent/HUP0002053A3/en unknown
- 1998-01-23 WO PCT/US1998/001317 patent/WO1998032753A1/en not_active Application Discontinuation
- 1998-01-23 ID IDW990755A patent/ID22273A/en unknown
- 1998-01-23 AU AU60384/98A patent/AU728812B2/en not_active Ceased
- 1998-01-27 AR ARP980100357A patent/AR011092A1/en unknown
- 1998-01-28 PE PE1998000064A patent/PE52299A1/en not_active Application Discontinuation
- 1998-01-28 HR HR9705041.3A patent/HRP980044A2/en not_active Application Discontinuation
-
1999
- 1999-07-23 IS IS5131A patent/IS5131A/en unknown
- 1999-07-27 NO NO993646A patent/NO993646L/en not_active Application Discontinuation
- 1999-08-24 BG BG103686A patent/BG103686A/en unknown
Also Published As
Publication number | Publication date |
---|---|
SK100099A3 (en) | 2000-05-16 |
BG103686A (en) | 2000-06-30 |
HUP0002053A2 (en) | 2001-08-28 |
EE9900328A (en) | 2000-02-15 |
HRP980044A2 (en) | 1998-10-31 |
HUP0002053A3 (en) | 2001-09-28 |
WO1998032753A1 (en) | 1998-07-30 |
AR011092A1 (en) | 2000-08-02 |
NO993646D0 (en) | 1999-07-27 |
NO993646L (en) | 1999-09-27 |
EP0968209A1 (en) | 2000-01-05 |
TR199902442T2 (en) | 2000-07-21 |
BR9807096A (en) | 2000-04-18 |
PL334833A1 (en) | 2000-03-27 |
IL131130A0 (en) | 2001-01-28 |
EA199900692A1 (en) | 2000-02-28 |
IS5131A (en) | 1999-07-23 |
AU6038498A (en) | 1998-08-18 |
PE52299A1 (en) | 1999-05-26 |
KR20000070568A (en) | 2000-11-25 |
JP2001509166A (en) | 2001-07-10 |
AU728812B2 (en) | 2001-01-18 |
CN1251099A (en) | 2000-04-19 |
CA2278739A1 (en) | 1998-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID22273A (en) | BENZENASULFONAMIDA TIAZOL AS A β AGONIST FOR TREATMENT OF DIABETES AND OBESITY | |
AP9901719A0 (en) | Treatment of diabetes with thiazolidinedione and metormin | |
AU3723297A (en) | Substituted sulfonamides as selective beta3 agonists for the treatment of diabetes and obesity | |
FR2754985B1 (en) | DELITABLE PRODUCT APPLICATOR AND APPLICATION ASSEMBLY COMPRISING SUCH AN APPLICATOR | |
ATE253338T1 (en) | FASTENING DEVICE AND PROSTHESIS PROVIDED THEREOF | |
DE69627513T2 (en) | COOKER AND ITS OPERATING PROCEDURE | |
IL128894A0 (en) | Materials and methods relating to the diagnosis and treatment of diabetes and obesity | |
IL121202A0 (en) | Hypoglycemic and hypolipidemic compounds | |
ID18730A (en) | FRICTION MATERIAL IS NOT ASBESTOS | |
ZA98647B (en) | Thiazole benzenesulfonamides as beta3 agonists for the treatment of diabetes and obesity | |
ID16889A (en) | ALKILAMINOBENZOTIAZOL AND BENZOKSAZOL COMPOUNDS | |
ID24173A (en) | 1,2,3,4,5,6 HEKSAHIDRO-2-6-METANO-3-BENZAZOSIN-10-OL, THE PROCESS OF MAKING AND USING IT FOR MEDICINES | |
AU7625898A (en) | Method and reagent for the treatment of a disease associated with interleukin-2 receptor gamma-chain expression | |
GB9718518D0 (en) | Fractionation of Hemicellulosic Materials | |
AU6269799A (en) | Adrenoleukodystrophy treatments and drug screening | |
ID24077A (en) | CLEANING MATERIAL AND PROCESS OF CHANNEL | |
ATA24597A (en) | DEVICE FOR DRAINING AND FASTENING LIGNOCELLULOSE MATERIAL | |
ID24065A (en) | TREATMENT OF DIABETES WITH TIOZOLIDINDINONE AND SULFONILUREA | |
GB9723258D0 (en) | Treatment of organic materials | |
SI0998291T1 (en) | Treatment of diabetes with thiazolidinedione and sulphonylurea | |
EP1009856A4 (en) | Novel molecules of the fthma-070-related protein family and the t85-related protein family and uses thereof | |
FR2767959B1 (en) | ROD-PICKING DEVICE AND ROD-PICKING ASSEMBLY COMPRISING SAME | |
ID16657A (en) | FRICTION MATERIAL IS NOT ASBESTOS | |
AU2837395A (en) | Friction materials containing blends of organic fibrous and particulate components | |
HUT74031A (en) | Activator for depolymerization of crosslinked polysiloxanes or/and of uncrosslinked polysiloxanes contained optionally filling material |